Related Experiment Video

Updated: Sep 27, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
10:10

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible

Debra Barton1, Charles Loprinzi

  • 1Mayo Clinic, Division of Medical Oncology, Rochester, MN 55905, USA.

Clinical Breast Cancer
|January 21, 2003
PubMed

Insights

Chemotherapy can cause cognitive dysfunction in breast cancer patients, with unknown causes and no current treatments. Research is exploring potential interventions to help patients maintain cognitive function.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Chemotherapy-induced cognitive dysfunction (CICD) is a significant clinical issue for breast cancer survivors.
  • The exact incidence, characteristics, and pathophysiology of CICD remain largely unknown.
  • Currently, no proven treatments exist to prevent or mitigate chemotherapy-related cognitive changes.

Purpose of the Study:

  • To review the current understanding of chemotherapy-induced cognitive dysfunction.
  • To explore potential mechanisms underlying cognitive changes after chemotherapy.
  • To identify novel interventions for clinical trials to treat CICD.

Main Methods:

  • Literature review of chemotherapy-induced cognitive dysfunction.
  • Analysis of potential pathophysiological mechanisms.
  • Identification of potential therapeutic strategies based on dementia and Alzheimer's disease research.

Main Results:

  • Cognitive changes may stem from indirect toxicity, oxidative damage, neuronal injury, inflammation, or autoimmune responses.
  • Several novel interventions show promise for treating CICD.
  • Interventions considered include hormonal therapies, antioxidants, and anti-inflammatory agents.

Conclusions:

  • Understanding the mechanisms of CICD is crucial for developing effective treatments.
  • Further clinical trials are needed to evaluate potential interventions for CICD.
  • A range of novel strategies, including pharmacological and behavioral approaches, could be explored.

More Related Videos

Therapeutic Massage for Psychological Well-being in Geriatric Oncology03:59

Therapeutic Massage for Psychological Well-being in Geriatric Oncology

Published on: May 22, 2026

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...